- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07859475
Shell Technique for Implant Site Development
Clinical and Radiographic Efficacy of Horizontal Alveolar Ridge Augmentation Using Shell Technique Via Autogenous Versus Xenogenic Bone Graft for Implant Site Development
The goal of this clinical trial is to learn if shell technique is useful for implant placement site preparation in adults. The main questions it aims to answer are:
Does using xenograft in this technique can reduce the amount of bone harvested from intra oral sites and reduce postoperative complications while offering enough bone to support endosseous implants with long term success?
Researchers will compare autogenous bone blocks to xenograft bone blocks in the shell technique ridge augmentation.
Participants will undergo ridge augmentation surgery, then have implants placed in the augmented area, then receive implant supported restorations afterwards.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Azza M Nasr, PhD
- Phone Number: +201003551727
- Email: azza.mo.nasr@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who are attending NGU clinics seeking rehabilitation of upper inter-bicuspid edentulous ridges.
- Edentulous ridges with adequate bone height, but inadequate bone width.
- Patients' ages are between 20-60 years.
- Medically free patients, who are nonsmokers.
- Good oral hygiene.
Exclusion Criteria:
- Patients who have undergone previous bone augmentation in the upper interbicuspid edentulous ridges.
- Edentulous ridges with inadequate bone height.
- Patients who have systemic diseases or who are taking drugs affecting quality of bone.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study group (Xenograft)
|
group will receive xenograft shell bone fixed to the edentulous ridge with a screw keeping it at a distance from the ridge and particulate xenograft to fill the gap. |
|
Active Comparator: Control group (Autograft)
|
group will receive autogenous bone shell harvested from the retromolar area fixed to the edentulous area with screws keeping it at a distance from the ridge and particulate bone to fill the gap formed of particulate autograft. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ridge width gain
Time Frame: 6 months
|
increase in the alveolar ridge width in millimeters |
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
implant survival
Time Frame: 12 months
|
12 months
|
|
|
Facial keratinized mucosal width
Time Frame: 6 months
|
6 months
|
|
|
Facial mucosal thickness
Time Frame: 6 months
|
facial mucosa thickness via transmucosal bone sounding |
6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NGU 7.5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.